NIH-funded research NIH-funded research

Exploring how gut bacteria influence immune system development

Official title: Dissecting microbiota-driven lymphangiogenesis in immune health and disease

Funded at University of Pittsburgh at Pittsburgh · NIH-10907807 · Data updated 2026-11-12

This study is looking at how certain bacteria in our gut, especially Helicobacter hepaticus, can influence our immune system and help us understand diseases like cancer and autoimmune disorders, so we can learn more about keeping our immune health in check.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Pittsburgh at Pittsburgh
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startAugust 15, 2023
Project endJuly 31, 2028
Funding year2024
Award (this year)$467,159
NIH project number5DP2AI177967-02
Project IDNIH-10907807 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with immune-based diseases such as cancer or autoimmune disorders.

Less likely to help

Patients without immune-related conditions or those not affected by gut microbiota may not benefit from this research.

What this research studies

This research investigates the relationship between gut microbiota and immune responses in both health and disease. It focuses on how specific gut bacteria, particularly Helicobacter hepaticus, can promote the development of lymphatic structures that are crucial for immune function. The study employs advanced techniques to analyze the signals and cell types involved in this process, aiming to uncover the mechanisms by which gut bacteria affect immune health. By understanding these interactions, the research seeks to provide insights into conditions like cancer and autoimmune diseases.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for managing immune-related diseases.

How similar studies have gone: Previous research has shown promising results in understanding the role of gut microbiota in immune health, suggesting that this approach could yield significant insights.

Where this research is happening

  • University of Pittsburgh at Pittsburgh
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Overacre-Delgoffe, Abigail E — University of Pittsburgh at Pittsburgh
  • Study coordinator: Overacre-Delgoffe, Abigail E

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.